HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.

Abstract
SM-10661 [(+/-)-(cis)-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl] displayed marked in vitro inhibition of rabbit platelet aggregation induced by 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (alkyl-PAF), 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16-PAF), and 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine, with IC50, values of 5.50, 5.94, and 3.68 microM, respectively. It also inhibited alkyl-PAF-induced aggregation of human platelets with an IC50 of 3.00 microM, but it did not inhibit platelet aggregation induced by ADP, collagen, arachidonic acid, the thromboxane A2 agonist U46619, or the Ca ionophore A23187, at concentrations up to 400 microM. Furthermore, SM-10661 antagonized [3H]-C16-PAF binding to rabbit platelets competitively, with an IC50 of 1.0 microM. SM-10661 protected against alkyl-PAF-induced lethality in mice with an ID50 of 6.0 mg/kg intravenously or 24 mg/kg orally. In guinea pig, SM-10661 inhibited the alkyl-PAF (0.1 micrograms/kg)-induced increase in bronchial pressure, with an ID50 of 0.7 mg/kg intravenously or 15 mg/kg orally. Bronchial hyperreactivity to bombesin after the infusion of alkyl-PAF was also inhibited dose-dependently by the infusion of SM-10661, with an ID50 of 25 mg/kg. In addition, SM-10661 inhibited alkyl-PAF (0.01 micrograms/kg)-induced hypotension in rats, with an ID50 of 0.36 mg/kg intravenously or 33 mg/kg orally. SM-10661, when given orally, showed rapid absorption and good duration of pharmacological activity in rats and rabbits.
AuthorsY Komuro, N Imanishi, M Uchida, S Morooka
JournalMolecular pharmacology (Mol Pharmacol) Vol. 38 Issue 3 Pg. 378-84 (Sep 1990) ISSN: 0026-895X [Print] United States
PMID2402227 (Publication Type: Journal Article)
Chemical References
  • Platelet Activating Factor
  • Thiazoles
  • Thiazolidines
  • 3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one
  • 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Topics
  • Administration, Oral
  • Animals
  • Blood Pressure (drug effects)
  • Bronchi (drug effects)
  • Guinea Pigs
  • Humans
  • Male
  • Mice
  • Mice, Inbred ICR
  • Platelet Activating Factor (analogs & derivatives, antagonists & inhibitors, metabolism)
  • Platelet Aggregation (drug effects)
  • Rabbits
  • Rats
  • Rats, Inbred Strains
  • Thiazoles (pharmacology)
  • Thiazolidines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: